Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01952821 · ClinicalTrials.gov registry record
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
A clinical trial of Head and Neck Cancer, sponsored by Mayo Clinic.
- Completed
- Registry status
- 66
- Enrollment target
- 1
- Study location
NCT01952821: Completed study of Head and Neck Cancer, sponsored by Mayo Clinic.
NCT01952821 is a study of Head and Neck Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 66 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01952821, a study of Head and Neck Cancer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish the Six-Minute Walk Test, 10-Meter Walk Test, 30 Second Chair Stand, Linear Analog Scale of Function, and the Modifed Brief Fatigue Inventory as reliable and valid outcome measurements for patients with head and neck cancer.
Conditions Studied
Interventions
- OTHER Six-Minute Walk Test
- OTHER 10-Meter Walk Test
- OTHER 30-Second Chair Stand
- OTHER Linear Analog Scale of Function
- OTHER Modified Brief Fatigue Inventory
Study Locations (1)
Arizona
- Mayo Clinic - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-01 |
What the finished NCT01952821 record still lists
NCT01952821 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 5 interventions - of which Six-Minute Walk Test is the first listed.
NCT01952821 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT01952821 about?
NCT01952821 is a clinical study titled "Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck". The purpose of this study is to establish the Six-Minute Walk Test, 10-Meter Walk Test, 30 Second Chair Stand, Linear Analog Scale of Function, and the Modifed Brief Fatigue Inventory as reliable and valid outcome measurements for patients with head and neck cancer.
What is the current status of trial NCT01952821?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2013-09. Estimated completion is 2015-01.
What conditions does trial NCT01952821 study?
This clinical trial studies the following conditions: Head and Neck Cancer.
What interventions are being tested in trial NCT01952821?
The interventions under investigation include: Six-Minute Walk Test (OTHER), 10-Meter Walk Test (OTHER), 30-Second Chair Stand (OTHER), Linear Analog Scale of Function (OTHER), Modified Brief Fatigue Inventory (OTHER).
Who is sponsoring clinical trial NCT01952821?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01952821 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01952821's enrollment target sits among peer trials
66 110th of 250 higher than 141 of 250 other Head and Neck Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia